Enaltec Pharma Research Private Limited

Enaltec Pharma Research Private Limited - pharma in Ambernath, Maharashtra, India. FY 2026 financials and compliance.
CIN U24230MH2005PTC153404 Incorporated 18 May 2005 ROC Mumbai HQ Ambernath, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹5.67 Cr
▼ 8.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹14.02 Lakh
Issued & subscribed
Open charges
₹14.68 Cr
Satisfied ₹48.85 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
40
Latest available

About Enaltec Pharma Research Private Limited

Data last updated: 16 February 2026

Enaltec Pharma Research Private Limited is a private limited company based in Ambernath, Maharashtra, India, a subsidiary of Enaltec Labs Private Limited. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 18 May 2005, the company has been in operation for over 21 years.

Registered with ROC Mumbai under CIN U24230MH2005PTC153404.

Capital: an authorised share capital of ₹30 Lakh and a paid-up capital of ₹14.02 Lakh. Formerly known as Getz Pharma Research Private Limited and Getz Pharma Private Limited. It is led by directors including Samir Kumar and Anand Prafulchandra Shah.

Last AGM: 11 August 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No Pl – 11 Midc Addl Ambernath, Maharashtra, India – 421506.

As per the financials filed for FY 2025, the company reported a revenue of ₹5.67 Cr, a decline of 8% compared to the previous year.

The company has a workforce of approximately 40 employees as per the latest available data. It operates as a subsidiary of Enaltec Labs Private Limited.

The company is associated with 1 brand - Enaltec Labs. As per MCA filings, the company has open charges of ₹14.68 Cr and satisfied charges of ₹48.85 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website enaltec.com.

Company Details of Enaltec Pharma Research Private Limited
CIN U24230MH2005PTC153404
Registration Number 153404
Incorporation Date 18 May 2005
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 11 August 2025
Date of Balance Sheet 31 March 2025
Parent Company Enaltec Labs Private Limited
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    Plot No Pl – 11 Midc Addl Ambernath, Maharashtra, India – 421506
  • Industry
    Pharma, Pharma Contract R&D
Company report
Enaltec Pharma Research Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Enaltec Pharma Research Private Limited report

Financials, compliance, directors, charges, ownership and filings for Enaltec Pharma Research Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Enaltec Pharma Research Private Limited

Enaltec Pharma Research Private Limited has undergone 3 name changes throughout its history. The company was previously known as Getz Pharma Research Private Limited, Getz Pharma Private Limited, and Enaltec Pharma Research Private Limited. The current legal name is Enaltec Pharma Research Private Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Enaltec Pharma Research Private Limited Current
Getz Pharma Research Private Limited Previous
Getz Pharma Private Limited Previous

Associated Brands with Enaltec Pharma Research Private Limited

Enaltec Pharma Research Private Limited operates one associated brand: Enaltec Labs. These brands represent Enaltec Pharma Research Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Non-oncology APIs are developed and manufactured by Enaltec Labs. enaltec.com

Competitors & Alternatives of Enaltec Pharma Research Private Limited

Brands and companies operating in the same space as Enaltec Pharma Research Private Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.

Competitor Description Location Founded
Laurus Labs Laurus Labs Pharmaceutical and biotechnology company Hyderabad, India, India 2005
Symbiotec Symbiotec Non-sterile steroid hormone-based APIs and intermediates are manufactured. Indore, India, India 2002
Beijing Biostar Technologies Beijing Biostar Technologies APIs, intermediates, and biochemical reagents are developed and manufactured. Beijing, China, China 2002
Sterling Pharma Solutions Sterling Pharma Solutions Contract development, manufacturing, and analytical services for APIs are offered. Dudley, United Kingdom, United Kingdom 2016
Provepharm Life Solutions Provepharm Life Solutions APIs and drug products are developed and valorized in pharmaceuticals. Marseille, France, France 1998
Hikal Hikal APIs and intermediates are produced via custom synthesis and research. Mumbai, India, India 1988
Snapdragon Chemistry Snapdragon Chemistry Drug discovery and development service provider Cambridge, United States, United States 2014
SeQuent SeQuent APIs are developed and manufactured for therapeutic areas. Bengaluru, India, India 2002
Jubilant Pharma Jubilant Pharma Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. Noida, India, India 1978

Business Activity of Enaltec Pharma Research Private Limited

Enaltec Pharma Research Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including scientific research and development.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
M Professional, Scientific and Technical M5 Scientific research and development Locked
Premium access

Business activity turnover details for Enaltec Pharma Research Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Enaltec Pharma Research Private Limited

Enaltec Pharma Research Private Limited is audited by Parikh & Associates for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
Parikh & Associates Locked Locked Locked
Premium access

Complete auditor history for Enaltec Pharma Research Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Enaltec Pharma Research Private Limited

Enaltec Pharma Research Private Limited is currently managed by 3 directors, with 13 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Samir Kumar Nominee Director 14 Feb 2022 4 Years 6 Months Current
Anand Prafulchandra Shah Managing Director 12 Sep 2009 16 Years 11 Months Current
Vivek Gupta Nominee Director 14 Feb 2022 4 Years 6 Months Current

Financials of Enaltec Pharma Research Private Limited FY 2025 filings available

Enaltec Pharma Research Private Limited reported revenue of ₹5.67 Cr (down 8.00% YoY) for FY 2025.

Revenue · FY 2025
₹5.67 Cr ▼ 8.00%
Premium access

Ten-year financial statements for Enaltec Pharma Research Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Enaltec Pharma Research Private Limited

Premium access

Shareholding and ownership data for Enaltec Pharma Research Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Enaltec Pharma Research Private Limited

Open charges
₹14.68 Cr
Satisfied charges
₹48.85 Cr
Breakdown by lending institutions
Idbi Bank Limited₹19.60 Cr
Hdfc Bank Limited₹14.68 Cr
State Bank of India₹10.30 Cr
Icici Bank Limited₹3.75 Cr
Bmw India Financial Services Private Limited₹0.52 Cr
Latest charge details
DateLenderAmountStatus
20 Oct 2020 Hdfc Bank Limited ₹1.18 Cr Satisfied
16 Mar 2018 Hdfc Bank Limited ₹10 Cr Satisfied
16 Mar 2018 Hdfc Bank Limited ₹3.5 Cr Satisfied
13 Sep 2013 Bmw India Financial Services Private Limited ₹32 Lakh Satisfied
06 Mar 2013 Icici Bank Limited ₹3.75 Cr Satisfied

Total charge records: 9 View all charges

Employees and EPFO Compliance at Enaltec Pharma Research Private Limited

Enaltec Pharma Research Private Limited has a workforce of 40 employees as of Sep 17, 2024.

Employee count
40
Active EPFO establishments
1
Employee growth
-35.48%
Premium access

Employee and EPFO history for Enaltec Pharma Research Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Enaltec Pharma Research Private Limited

Premium access

GST registrations and filing compliance for Enaltec Pharma Research Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Enaltec Pharma Research Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Enaltec Pharma Research Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Enaltec Pharma Research Private Limited

Premium access

MSME payment history for Enaltec Pharma Research Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Enaltec Pharma Research Private Limited

Premium access

Corporate group structure for Enaltec Pharma Research Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Enaltec Pharma Research Private Limited

Premium access

MCA filings and documents for Enaltec Pharma Research Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Enaltec Pharma Research Private Limited

Activity
11 Aug 2025
Enaltec Pharma Research Private Limited last Annual general meeting of members was held on 11 Aug 2025 as per latest MCA records.
Activity
31 Mar 2025
Enaltec Pharma Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
31 Jan 2025
A charge registered on 20 Oct 2020 via Charge ID 100386842 with Hdfc Bank Limited was fully satisfied on 31 Jan 2025.
Charges
31 Jan 2025
A charge registered on 16 Mar 2018 via Charge ID 100176358 with Hdfc Bank Limited was fully satisfied on 31 Jan 2025.
Charges
31 Jan 2025
A charge registered on 16 Mar 2018 via Charge ID 100176362 with Hdfc Bank Limited was fully satisfied on 31 Jan 2025.
Directors
14 Feb 2022
Samir Kumar was appointed as a Nominee Director on 14 Feb 2022 & has been associated with this company since 4 years 6 months.

Frequently Asked Questions about Enaltec Pharma Research Private Limited

Enaltec Pharma Research Private Limited is an active private limited company in the pharma sector based in Ambernath, Maharashtra, India. It was incorporated on 18 May 2005 (21+ years old) and is registered under CIN U24230MH2005PTC153404. The company has 40 employees.

Enaltec Pharma Research Private Limited reported revenue of ₹5.67 Cr for FY 2025 (down 8.00% YoY).

The current directors of Enaltec Pharma Research Private Limited are:

The primary industry of Enaltec Pharma Research Private Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.

Enaltec Pharma Research Private Limited can be reached at the registered office: Plot No Pl – 11 Midc Addl Ambernath, Maharashtra, India – 421506, or through the website enaltec.com.

The authorised capital is ₹30 Lakh, and the paid-up capital is ₹14.02 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available